Glypican 2

Glypican 2 Overview

English NameGlypican-2Approved Drugs0
Drugs in Clinical Trials2Target SynonymCerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Highest Development StagePhase 1 Clinical
English NameGlypican-2
Target SynonymCerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 1 Clinical

Glypican 2 Product List

  • Product Category

    Protein (7)

  • Product Status

    Launched (7)

  • Species

    Human (4)Mouse (1)Rhesus macaque (2)

  • Tag

    His Tag (3)Fc Tag (1)Llama IgG Fc Tag (1)His Tag & Avi Tag (2)

  • Conjugate

    Unconjugated (5)Biotin-labeled (2)

Glypican 2 Background

Glypican 2 (GPC2), also known cerebroglycan, is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons. Cerebroglycan has especially high affinity for laminin-1. GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models. A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.

Glypican 2 Synonyms

Glypican 2,GPC2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma)Phase 1 ClinicalChildrens Hospital of PhiladelphiaRhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics)TmGPC2-01-CAR-TPhase 1 ClinicalChildrens Hospital of PhiladelphiaSmall Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland